Tavernerio, Italy

Mary Psilogenis



Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Mary Psilogenis

Introduction

Mary Psilogenis is a notable inventor based in Tavernerio, Italy. She has made significant contributions to the field of medicine, particularly in the management of delayed onset emesis. Her innovative approach has the potential to improve patient care and treatment outcomes.

Latest Patents

Mary Psilogenis holds a patent for her invention titled "Nasal administration of agents for treatment of delayed onset emesis." This invention focuses on a method for the prophylactic management of delayed emesis through the use of metoclopramide nasal spray. This advancement offers a new avenue for patients suffering from this condition.

Career Highlights

Throughout her career, Mary has worked with reputable companies in the pharmaceutical industry. Notably, she has been associated with Ribogene, Inc. and Evoke Pharma, Inc. Her experience in these organizations has contributed to her expertise and innovative capabilities.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Mary Psilogenis exemplifies the spirit of innovation in the medical field. Her work not only highlights her dedication to improving patient care but also showcases the importance of inventive solutions in addressing healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…